Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Synchrony Financial SYF: This consumer financial services company has seen the Zacks Consensus Estimate for its current year earnings increasing 18.2% over the last 60 days.

$Synchrony Financial(SYF-B)$ Price and Consensus

Synchrony Financial price-consensus-chart | Synchrony Financial Quote

SouthState Corporation SSB: This bank holding company for SouthState Bank has seen the Zacks Consensus Estimate for its current year earnings increasing 7.8% over the last 60 days.

SouthState Corporation Price and Consensus

SouthState Corporation price-consensus-chart | SouthState Corporation Quote

Veracyte, Inc. VCYT: This diagnostics company has seen the Zacks Consensus Estimate for its current year earnings increasing 20.4% over the last 60 days.

Veracyte, Inc. Price and Consensus

Veracyte, Inc. price-consensus-chart | Veracyte, Inc. Quote

Day One Biopharmaceuticals, Inc. DAWN: This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 17.1% over the last 60 days.

Day One Biopharmaceuticals, Inc. Price and Consensus

Day One Biopharmaceuticals, Inc. price-consensus-chart | Day One Biopharmaceuticals, Inc. Quote

Financial Institutions, Inc. FISI: This holding company for the Five Star Bank has seen the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.

Financial Institutions, Inc. Price and Consensus

Financial Institutions, Inc. price-consensus-chart | Financial Institutions, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Financial Institutions, Inc. (FISI) : Free Stock Analysis Report

Synchrony Financial (SYF) : Free Stock Analysis Report

Veracyte, Inc. (VCYT) : Free Stock Analysis Report

SouthState Corporation (SSB) : Free Stock Analysis Report

Day One Biopharmaceuticals, Inc. (DAWN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research